MUSC Research Nexus Clinic (Site 210-002), 96 Jonathan Lucas St., CSB 214 — Charleston, South Carolina

MUSC Research Nexus Clinic (Site 210-002), 96 Jonathan Lucas St., CSB 214 is a clinical research site located in Charleston, South Carolina, United States 29425.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

MUSC Research Nexus Clinic (Site 210-002), 96 Jonathan Lucas St., CSB 214 has participated in 6 clinical trials.

Therapeutic areas: COVID-19, Covid19.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Charleston

Browse all research sites in South Carolina · View every site in Charleston

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MUSC Research Nexus Clinic (Site 210-002), 96 Jonathan Lucas St., CSB 214?

MUSC Research Nexus Clinic (Site 210-002), 96 Jonathan Lucas St., CSB 214 has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MUSC Research Nexus Clinic (Site 210-002), 96 Jonathan Lucas St., CSB 214 conducted?

MUSC Research Nexus Clinic (Site 210-002), 96 Jonathan Lucas St., CSB 214 has 6 clinical trials on record. Their work covers COVID-19, Covid19.

Is MUSC Research Nexus Clinic (Site 210-002), 96 Jonathan Lucas St., CSB 214 accredited by Crixeo Clinical Trials?

MUSC Research Nexus Clinic (Site 210-002), 96 Jonathan Lucas St., CSB 214 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MUSC Research Nexus Clinic (Site 210-002), 96 Jonathan Lucas St., CSB 214?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.